HBIO

Harvard Bioscience
$8.15
+$0.20 (+2.52%)Sep 10, 2026
4.8NeutralMoatMint rating

MoatMint rates Harvard Bioscience (HBIO) 4.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 7.7 out of 10.

Key metrics

The numbers that frame HBIO today
Market cap
$37.10M
P/E (TTM)
-3.6
EV / FCF
-40.0
Gross margin
58.2%
EV / Sales
0.8
ROIC
-5.7%
Div yield
0%
Debt / equity
5.7
52wk Low
$3.76
52wk High
$9.40

HBIO stock rating

How HBIO scores on quality, value, growth, momentum and financial health
4.8out of 10
Neutral overallFair business, full price
Quality7.7
Growth2.0
Momentum6.0
Value3.5
Financial Health2.9

Growth

Revenue and earnings trend for HBIO
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about HBIO
Is Harvard Bioscience a good buy?
Hold. Harvard Bioscience has excellent quality and strong momentum. Both signals support the setup. Growth looks poor, and that is what holds the overall call back. We think Harvard Bioscience is selling at a high price.
What is the market capitalization of HBIO?
Harvard Bioscience's market capitalization is $37.10M.
What is the P/E ratio for HBIO stock?
Harvard Bioscience's current P/E ratio is -3.6.
What is the 52-week high for HBIO stock?
The 52-week high for Harvard Bioscience is $9.40. The current close of $8.15 is 13.3% below that high.
What is the 52-week low for HBIO stock?
The 52-week low for Harvard Bioscience is $3.76. The current close of $8.15 is 117% above that low.
Does HBIO stock pay dividends?
Harvard Bioscience does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for HBIO?
Harvard Bioscience's Debt / Equity ratio is 5.74.